This also explains why their one-year HCC recurrence rate in the IFN-containing group was much higher than that in previous studies reported from Japan (one-year: 26%–35% vs. 0%–9.5%) [40,41]. This evidence concerns the gene IFNA1 and hepatocellular carcinoma.